Evidence map›Paper›PMID 32523118›Full record

ArticleNature2020

The architecture of the Gram-positive bacterial cell wall.

L Pasquina-Lemonche, J Burns, R D Turner, S Kumar, R Tank, N Mullin, J S Wilson, B Chakrabarti, P A Bullough, S J Foster and 1 more

Abstract read
In one paragraph

Article in Nature, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 181 papers.

0numbers the graph read from it
0cells of the map it votes in
181citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

181 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Advances in BODIPY Derivatives for Antibacterial Phototherapy.Angewandte Chemie (International ed. in English) · 2026
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. mBio · 2026
    Article
  20. Article

121 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

L Pasquina-Lemonche *Krebs Institute, University of Sheffield, Sheffield, UK.ORCID http://orcid.org/0000-0002-8592-9542
J Burns *Krebs Institute, University of Sheffield, Sheffield, UK.
R D TurnerKrebs Institute, University of Sheffield, Sheffield, UK.
S KumarKrebs Institute, University of Sheffield, Sheffield, UK.ORCID http://orcid.org/0000-0002-2358-2344
R TankKrebs Institute, University of Sheffield, Sheffield, UK.
N MullinKrebs Institute, University of Sheffield, Sheffield, UK.ORCID http://orcid.org/0000-0003-4571-2362
J S WilsonKrebs Institute, University of Sheffield, Sheffield, UK.ORCID http://orcid.org/0000-0002-6967-0809
B ChakrabartiDepartment of Physics and Astronomy, University of Sheffield, Sheffield, UK.ORCID http://orcid.org/0000-0003-2699-4157
P A BulloughKrebs Institute, University of Sheffield, Sheffield, UK.ORCID http://orcid.org/0000-0001-8147-1127
S J FosterKrebs Institute, University of Sheffield, Sheffield, UK. s.foster@sheffield.ac.uk.ORCID http://orcid.org/0000-0001-7432-7805
J K HobbsKrebs Institute, University of Sheffield, Sheffield, UK. jamie.hobbs@sheffield.ac.uk.ORCID http://orcid.org/0000-0002-5872-1404

Funding

Medical Research Council MR/N002679/1Wellcome Trust 212197
6 · The paper itself

Abstract

The primary structural component of the bacterial cell wall is peptidoglycan, which is essential for viability and the synthesis of which is the target for crucial antibiotics

Indexed as

Microscopy, Atomic ForceBacillus subtilisCell WallMicrobial ViabilityPeptidoglycanStaphylococcus aureusPeptidoglycan

Identifiers

PMID32523118
PMCPMC7308169

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.